Position in CLDI
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$18,108
-$6,746 QoQ
Shares Held
4,736
+256.6% QoQ
Ownership
0.183%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Virtu Financial LLC holds $37,794,912 across 147 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
58,459 | $4,130,128 | |
| 2 | 29,790 | $3,954,026 | |||
| 3 | ABVX |
Abivax S.A.
|
19,155 | $2,552,595 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
9,220 | $2,256,779 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
12,556 | $1,439,796 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
8,163 | $1,000,620 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
17,524 | $962,768 | |
| 8 | IOVA |
Iovance Biotherapeutics, Inc.
|
221,500 | $921,440 |
All Filings in CLDI
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,108 | 75,769 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $24,854 | 21,243 | Shares | Defined | 2026-02-23 | |
| 2025-06-30 | $2 | 10,240 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $30,981 | 54,737 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $84,465 | 73,448 | Shares | Defined | 2025-02-11 | |
| 2024-06-30 | $5,192 | 25,965 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $23,765 | 42,062 | Shares | Defined | 2024-05-20 | |
| 2023-03-31 | $311,879 | 30,368 | Shares | Defined | 2023-05-01 | |
| 2022-12-31 | $131,264 | 12,907 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $783,754 | 79,569 | Shares | Defined | 2022-11-07 | |
| No filing history on record for this holder in this stock. | ||||||